Sangamo Therapeutics
SGMO
#10606
Rank
C$42.83 M
Marketcap
C$0.10
Share price
0.00%
Change (1 day)
-87.03%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -C$0.16 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are C$34.55 Million. In 2025 the company made an earning of -C$0.16 Billion a decrease over its 2024 earnings that were of -C$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.16 Billion0.99%
2025 -C$0.16 Billion9.71%
2024 -C$0.14 Billion-17.27%
2023 -C$0.17 Billion-40.88%
2022 -C$0.29 Billion9.79%
2021 -C$0.26 Billion41.52%
2020 -C$0.19 Billion23.17%
2019 -C$0.15 Billion36.33%
2018 -C$0.11 Billion36.89%
2017 -C$78.76 Million-22.32%
2016 -C$0.11 Billion54.86%
2015 -C$65.48 Million75.62%
2014 -C$37.29 Million0.13%
2013 -C$37.24 Million
2011 -C$50.06 Million43.66%
2010 -C$34.85 Million28.52%
2009 -C$27.12 Million-23.55%
2008 -C$35.47 Million2.45%
2007 -C$34.62 Million19.5%
2006 -C$28.97 Million50.78%
2005 -C$19.22 Million75%
2004 -C$10.98 Million-33.25%
2003 -C$16.45 Million-62.27%
2002 -C$43.59 Million102.82%
2001 -C$21.5 Million23.21%
2000 -C$17.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.62 B-23,855.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$14.37 B-9,424.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$1.41 B-1,016.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-C$1.4 Billion 803.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-C$2.74 Billion 1,672.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.74 B-7,070.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$1.57 B-1,119.42%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.20 B-235.16%๐Ÿ‡บ๐Ÿ‡ธ USA